In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

ConvaTec completes £1.5bn IPO on LSE

Executive Summary

ConvaTec Inc. (devices, accessories, and supplies for the hospital market to treat and manage chronic conditions) grossed approximately £1.47bn ($1.8bn) in its initial public offering on the London Stock Exchange. The company issued new shares at a price of £2.25 (the low end of its anticipated range) to certain institutional and other investors in the UK and outside the US. Following the close of the IPO, Nordic Capital and Avista Capital Partners will respectively hold 45.1% and 19.5% ownership stakes. ConvaTec will use most of the proceeds to repay existing debt.
Deal Industry
  • Medical Devices
  • Services
  • Medical Devices
    • Consumables, Central Supplies
    • Infusion Therapy Equipment and Supplies
    • Monitoring Equipment & Devices
    • Rehabilitation Equipment and Devices
    • Surgical Equipment & Devices
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies